CellAegis Devices Inc., a Toronto based developer of proprietary, automated, noninvasive autoRIC Device for Remote Ischemic Conditioning (RIC), has raised US $9.5 million from five investors including CTI Life Sciences Fund, ZOLL Medical Corporation, and Broadview Ventures.
Shermaine Tilley, Managing Partner of CTI Life Sciences Fund, and Eric Knudsen, Director of Business Development of ZOLL Medical have joined CellAegis board of directors which is chaired by John Berton, co-founder of CellAegis, and co-founder & General Partner of Georgian Partners.
The newly reconstituted board includes new director Dr. Andrew Redington, Head of Cardiology at The Hospital for Sick Children (SickKids), existing directors, CEO Rocky Ganske, Donna Parr, President of Crimson Capital, Brian Roberts, and previous board observer Christopher H. Colecchi, Managing Director of Broadview Ventures.
updated: the amount from $3.1M to $9.5M.
photo credit: CellAegis Devices